These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34420860)

  • 81. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
    Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer.
    Inoue T; Inoue T; Teshima T; Murayama S; Shimizutani K; Fuchihata H; Furukawa S
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1201-4. PubMed ID: 8985043
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
    Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
    Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial.
    Tissaverasinghe S; Crook J; Bachand F; Batchelar D; Hilts M; Araujo C; Anderson D; Bainbridge T; Farnquist B
    Brachytherapy; 2019; 18(3):299-305. PubMed ID: 30795889
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.
    Arthur DW; Koo D; Zwicker RD; Tong S; Bear HD; Kaplan BJ; Kavanagh BD; Warwicke LA; Holdford D; Amir C; Archer KJ; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):681-9. PubMed ID: 12788173
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.
    Shah C; Lanni TB; Ghilezan MI; Gustafson GS; Marvin KS; Ye H; Vicini FA; Martinez AA
    Brachytherapy; 2012; 11(6):441-5. PubMed ID: 22728157
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer.
    Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
    Brachytherapy; 2018; 17(3):517-523. PubMed ID: 29496423
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Brachytherapy for stage IIIB squamous cell carcinoma of the uterine cervix: survival and toxicity.
    Zuliani AC; Cunha Mde O; Esteves SC; Teixeira JC
    Rev Assoc Med Bras (1992); 2010; 56(1):37-40. PubMed ID: 20339784
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
    Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
    Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
    Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ
    Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Biological effective dose evaluation in gynaecological brachytherapy: LDR and HDR treatments, dependence on radiobiological parameters, and treatment optimisation.
    Bianchi C; Botta F; Conte L; Vanoli P; Cerizza L
    Radiol Med; 2008 Oct; 113(7):1068-78. PubMed ID: 18618074
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide.
    Avila S; Ruiz MJ; Petereit D; Arya R; Callender B; Hasan Y; Kim J; Lee N; McCall A; Son C; Stack K; Asif S; Besecker T; Juneja A; Li Z; Naik P; Ranka T; Saxena P; Siegfried B; Ichikawa T; Golden DW
    Brachytherapy; 2023; 22(3):352-360. PubMed ID: 36681540
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors.
    Karagiannis E; Strouthos I; Leczynski A; Zamboglou N; Ferentinos K
    Front Oncol; 2022; 12():800920. PubMed ID: 35299745
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Tuberculosis in quebec: a review of trends.
    Klotz A; Harouna A; Smith AF
    J Public Health Res; 2012 Jun; 1(2):158-64. PubMed ID: 25170460
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Characterizing Trends in the Use of Food Donations and Other Food-Related Community-Based Social Assistance Programs in a Cohort of New Food Bank Users in Quebec, Canada.
    Pérez EJ; Carabali M; Mercille G; Sylvestre MP; Roncarolo F; Potvin L
    Int J Public Health; 2024; 69():1605833. PubMed ID: 38404502
    [No Abstract]   [Full Text] [Related]  

  • 98. Health Services Research in Brachytherapy: Current Understanding and Future Challenges.
    Defourny N; Mackenzie P; Spencer K
    Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):548-555. PubMed ID: 36941146
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Utilization of brachytherapy in Quebec, Canada.
    Lecavalier-Barsoum M; Khosrow-Khavar F; Asiev K; Popovic M; Vuong T; Enger SA
    Brachytherapy; 2021; 20(6):1282-1288. PubMed ID: 34420860
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.